JNJ - Johnson & Johnson Stock Price, Fair Value and News

160.66USD+1.02 (+0.64%)Market Closed

Market Summary

USD160.66+1.02

Market Closed

0.64%

JNJ Stock Price

View Fullscreen

JNJ RSI Chart

JNJ Valuation

Market Cap

386.7B

Price/Earnings (Trailing)

10.17

Price/Sales (Trailing)

4.47

EV/EBITDA

14.28

Price/Free Cashflow

19.05

JNJ Price/Sales (Trailing)

JNJ Profitability

EBT Margin

22.53%

Return on Equity

53.14%

Return on Assets

20.99%

Free Cashflow Yield

5.25%

JNJ Fundamentals

JNJ Revenue

Revenue (TTM)

86.6B

Rev. Growth (Yr)

4.31%

Rev. Growth (Qtr)

4.98%

JNJ Earnings

Earnings (TTM)

38.0B

Earnings Growth (Yr)

-8.9%

Earnings Growth (Qtr)

43.96%

Breaking Down JNJ Revenue

Last 7 days

2.8%

Last 30 days

8.5%

Last 90 days

9.3%

Trailing 12 Months

-7.5%

How does JNJ drawdown profile look like?

JNJ Financial Health

Current Ratio

1.07

Debt/Equity

0.44

Debt/Cashflow

0.78

JNJ Investor Care

Dividend Yield

2.99%

Dividend/Share (TTM)

4.81

Buy Backs (1Y)

7.37%

Diluted EPS (TTM)

15.15

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	85.6B	86.6B	0	0
2023	81.0B	82.3B	83.7B	85.2B
2022	76.3B	73.2B	69.8B	80.0B
2021	84.2B	89.2B	91.4B	78.7B
2020	82.7B	80.5B	80.9B	82.6B
2019	81.6B	81.3B	81.7B	82.1B
2018	78.7B	80.7B	81.4B	81.6B
2017	72.2B	72.5B	74.4B	76.5B
2016	70.2B	70.9B	71.6B	71.9B
2015	73.6B	71.9B	70.5B	70.1B
2014	71.9B	73.5B	74.4B	74.3B
2013	68.6B	70.0B	70.5B	71.3B
2012	65.0B	64.9B	65.9B	67.2B
2011	62.1B	63.4B	64.4B	65.0B
2010	62.5B	62.6B	62.5B	61.6B
2009	62.6B	61.4B	60.5B	61.9B
2008	0	62.0B	62.9B	63.7B
2007	0	0	0	61.1B

Get all data in R, Python etc through our Historical Stock Data APIs

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment provides skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. This segment also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment provides products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes, and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment offers electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and contact lenses and ophthalmic technologies related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.

CEO	Mr. Joaquin Duato
WEBSITE	jnj.com
INDUSTRY	Pharmaceuticals
EMPLOYEES	65535

Johnson & Johnson Frequently Asked Questions

What is the ticker symbol for Johnson & Johnson? What does JNJ stand for in stocks?

JNJ is the stock ticker symbol of Johnson & Johnson. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Johnson & Johnson (JNJ)?

As of Thu Jul 25 2024, market cap of Johnson & Johnson is 372.31 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of JNJ stock?

You can check JNJ's fair value in chart for subscribers.

Is Johnson & Johnson a good stock to buy?

The fair value guage provides a quick view whether JNJ is over valued or under valued. Whether Johnson & Johnson is cheap or expensive depends on the assumptions which impact Johnson & Johnson's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for JNJ.

What is Johnson & Johnson's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Jul 25 2024, JNJ's PE ratio (Price to Earnings) is 9.79 and Price to Sales (PS) ratio is 4.3. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. JNJ PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Johnson & Johnson's stock?

In the past 10 years, Johnson & Johnson has provided 0.071 (multiply by 100 for percentage) rate of return.